Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 145

1.

Maternal vitamin D supplementation during pregnancy and lactation to promote infant growth in Dhaka, Bangladesh (MDIG trial): study protocol for a randomized controlled trial.

Roth DE, Gernand AD, Morris SK, Pezzack B, Islam MM, Dimitris MC, Shanta SS, Zlotkin SH, Willan AR, Ahmed T, Shah PS, Murphy KE, Weksberg R, Choufani S, Shah R, Al Mahmud A.

Trials. 2015 Jul 14;16:300. doi: 10.1186/s13063-015-0825-8.

2.

Evaluating processes of care and outcomes of children in hospital (EPOCH): study protocol for a randomized controlled trial.

Parshuram CS, Dryden-Palmer K, Farrell C, Gottesman R, Gray M, Hutchison JS, Helfaer M, Hunt E, Joffe A, Lacroix J, Nadkarni V, Parkin P, Wensley D, Willan AR; Canadian Critical Care Trials Group.

Trials. 2015 Jun 2;16:245. doi: 10.1186/s13063-015-0712-3.

3.

Patient safety, resident well-being and continuity of care with different resident duty schedules in the intensive care unit: a randomized trial.

Parshuram CS, Amaral AC, Ferguson ND, Baker GR, Etchells EE, Flintoft V, Granton J, Lingard L, Kirpalani H, Mehta S, Moldofsky H, Scales DC, Stewart TE, Willan AR, Friedrich JO; Canadian Critical Care Trials Group.

CMAJ. 2015 Mar 17;187(5):321-9. doi: 10.1503/cmaj.140752. Epub 2015 Feb 9.

4.

Effect of oximetry on hospitalization in bronchiolitis: a randomized clinical trial.

Schuh S, Freedman S, Coates A, Allen U, Parkin PC, Stephens D, Ungar W, DaSilva Z, Willan AR.

JAMA. 2014 Aug 20;312(7):712-8. doi: 10.1001/jama.2014.8637.

5.

Using value-of-information methods when the disease is rare and the treatment is expensive--the example of hemophilia A.

Abrahamyan L, Willan AR, Beyene J, Mclimont M, Blanchette V, Feldman BM; Canadian Hemophilia Primary Prophylaxis (CHPS) Study Group.

J Gen Intern Med. 2014 Aug;29 Suppl 3:S767-73. doi: 10.1007/s11606-014-2880-3.

6.

Impact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial.

Freedman SB, Williamson-Urquhart S, Schuh S, Sherman PM, Farion KJ, Gouin S, Willan AR, Goeree R, Johnson DW, Black K, Schnadower D, Gorelick MH; Pediatric Emergency Research Canada (PERC) Gastroenteritis Study Group.

Trials. 2014 May 14;15:170. doi: 10.1186/1745-6215-15-170.

7.

More evidence that unnecessary antenatal treatments cause harm--reply.

Asztalos EV, Willan AR, Matthews SG.

JAMA Pediatr. 2014 Apr;168(4):389-90. doi: 10.1001/jamapediatrics.2013.5244. No abstract available.

PMID:
24710588
8.

Planned cesarean or vaginal delivery for twin pregnancy.

Barrett JF, Willan AR, Joseph KS.

N Engl J Med. 2014 Jan 16;370(3):280. doi: 10.1056/NEJMc1314560. No abstract available.

9.

Underestimation of uncertainties in health utilities derived from mapping algorithms involving health-related quality-of-life measures: statistical explanations and potential remedies.

Chan KK, Willan AR, Gupta M, Pullenayegum E.

Med Decis Making. 2014 Oct;34(7):863-72. doi: 10.1177/0272989X13517750. Epub 2014 Jan 9.

PMID:
24407513
10.

Value of information methods for assessing a new diagnostic test.

Chen MH, Willan AR.

Stat Med. 2014 May 20;33(11):1801-15. doi: 10.1002/sim.6085. Epub 2014 Jan 9.

PMID:
24403241
11.

Multiple courses of antenatal corticosteroids for preterm birth study: outcomes in children at 5 years of age (MACS-5).

Asztalos EV, Murphy KE, Willan AR, Matthews SG, Ohlsson A, Saigal S, Armson BA, Kelly EN, Delisle MF, Gafni A, Lee SK, Sananes R, Rovet J, Guselle P, Amankwah K, Saleem M, Sanchez J; MACS-5 Collaborative Group.

JAMA Pediatr. 2013 Dec;167(12):1102-10. doi: 10.1001/jamapediatrics.2013.2764.

PMID:
24126948
12.

A randomized trial of planned cesarean or vaginal delivery for twin pregnancy.

Barrett JF, Hannah ME, Hutton EK, Willan AR, Allen AC, Armson BA, Gafni A, Joseph KS, Mason D, Ohlsson A, Ross S, Sanchez JJ, Asztalos EV; Twin Birth Study Collaborative Group.

N Engl J Med. 2013 Oct 3;369(14):1295-305. doi: 10.1056/NEJMoa1214939. Erratum in: N Engl J Med. 2013 Dec 12;369(24):2364.

13.

The impact of pedestrian countdown signals on pedestrian-motor vehicle collisions: a reanalysis of data from a quasi-experimental study.

Richmond SA, Willan AR, Rothman L, Camden A, Buliung R, Macarthur C, Howard A.

Inj Prev. 2014 Jun;20(3):155-8. doi: 10.1136/injuryprev-2012-040717. Epub 2013 Sep 23. Erratum in: Inj Prev. 2014 Feb;20(1):40.

14.

A flexible nonparametric approach to find candidate genes associated with disease in microarray experiments.

Hossain A, Willan AR, Beyene J.

J Bioinform Comput Biol. 2013 Apr;11(2):1250021. doi: 10.1142/S0219720012500217. Epub 2012 Oct 24.

PMID:
23600812
15.

Optimal global value of information trials: better aligning manufacturer and decision maker interests and enabling feasible risk sharing.

Eckermann S, Willan AR.

Pharmacoeconomics. 2013 May;31(5):393-401. doi: 10.1007/s40273-013-0038-5. Review.

PMID:
23529209
16.

Maternal and infant predictors of attendance at Neonatal Follow-Up programmes.

Ballantyne M, Stevens B, Guttmann A, Willan AR, Rosenbaum P.

Child Care Health Dev. 2014 Mar;40(2):250-8. doi: 10.1111/cch.12015. Epub 2013 Jan 7.

PMID:
23294101
17.

Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods.

Chen MH, Willan AR.

Clin Trials. 2013 Feb;10(1):54-62. doi: 10.1177/1740774512467404. Epub 2012 Dec 21.

PMID:
23263520
18.

Bias-corrected estimator for intraclass correlation coefficient in the balanced one-way random effects model.

Atenafu EG, Hamid JS, To T, Willan AR, Feldman BM, Beyene J.

BMC Med Res Methodol. 2012 Aug 20;12:126. doi: 10.1186/1471-2288-12-126.

19.

Value of information methods for planning and analyzing clinical studies optimize decision making and research planning.

Willan AR, Goeree R, Boutis K.

J Clin Epidemiol. 2012 Aug;65(8):870-6. doi: 10.1016/j.jclinepi.2012.01.017. Epub 2012 May 18.

PMID:
22609138
20.

Value of information and pricing new healthcare interventions.

Willan AR, Eckermann S.

Pharmacoeconomics. 2012 Jun 1;30(6):447-59. doi: 10.2165/11592250-000000000-00000.

PMID:
22591129
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk